Organization: Health Canada
Year: 2021
Month: December
Request Number: A-2021-000987
Request Summary: Adverse Drug Reactions (ADRs) for Vedolizumab. Report numbers: E2B_04124210,E2B_04109790, E2B_04185970, E2B_04118452, E2B_04228594. ADRs for Ondansetron. Report numbers: E2B_04198175, E2B_04166817, 952157, 953433. ADR for Pantoloc. Report number: 951454. ADRs for Pantoprazole sodium. Report numbers: E2B_04142970, E2B_04186572, E2B_04175116, E2B_04129042, E2B_04122589, E2B_04219291, 951454. ADR for Tecta. Report number: 951343.
Disposition: Disclosed in part
Number of pages: 265